Wire · regulatory
US plans to appoint two new FDA deputy commissioners for tech and drugs, CNBC reports
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 26 August 2026 · Fusion42 review
The US Department of Health and Human Services plans to appoint two new deputy commissioners at the FDA, one focusing on technology including healthcare and AI, and another on drugs, as part of an agency restructure. These appointments reflect a shift towards specialised oversight in emerging tech and pharmaceuticals under the new FDA leadership.
This Wire brief sits within Fusion42's coverage of Health, and 4 sources have reported it between 25 Aug 2026 and 26 Aug 2026.
◆ ◆ The Wire takeaway
You face new regulatory gates shaped by tech-savvy FDA leaders with an AI lens, requiring earlier engagement on digital health products. The split focus signals heightened scrutiny but also clearer pathways for drug approval, turning compliance into opportunity.
◆ Coverage
4 sources · first reported 25 Aug 2026 · latest 26 Aug 2026
◆ Related on Wire
◆ Topics